DOXOrubicin is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:

Emergency Central

-- The first section of this topic is shown below --

General

High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.

Pronunciation:
dox-oh-roo-bi-sin


Trade Name(s)

  • Adriamycin Canadian Tradename
  • Caelyx Canadian Tradename
  • Myocet Canadian Tradename

Ther. Class.
antineoplastics

Pharm. Class.
anthracyclines

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - DOXOrubicin ID - 109422 Y1 - 2019 PB - Davis's Drug Guide UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109422/all/DOXOrubicin ER -